{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T05:42:03Z","timestamp":1793770923219,"version":"4.6.1"},"reference-count":129,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,9,5]],"date-time":"2025-09-05T00:00:00Z","timestamp":1757030400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,9,5]],"date-time":"2025-09-05T00:00:00Z","timestamp":1757030400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Egypt Heart J"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>ST-elevation myocardial infarction (STEMI) is a major cardiac event that requires rapid reperfusion therapy. The same reperfusion mechanism that minimizes infarct size and mortality may paradoxically exacerbate further cardiac damage\u2014a condition known as reperfusion injury. Oxidative stress, calcium excess, mitochondrial malfunction, and programmed cell death mechanisms make myocardial dysfunction worse. Even with the best revascularization techniques, reperfusion damage still jeopardizes the long-term prognosis and myocardial healing.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>A thorough narrative review was carried out using some of the most well-known scientific databases, including ScienceDirect, PubMed, and Google Scholar. With an emphasis on pathophysiological causes, clinical manifestations, innovative biomarkers, imaging modalities, artificial intelligence applications, and developing treatment methods related to reperfusion injury, peer-reviewed publications published between 2015 and 2025 were highlighted.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Main body<\/jats:title>\n                    <jats:p>The review focuses on the molecular processes that underlie cardiac reperfusion injury, such as reactive oxygen species, calcium dysregulation, opening of the mitochondrial permeability transition pore, and several types of programmed cell death. Clinical syndromes such as myocardial stunning, coronary no-reflow, and intramyocardial hemorrhage are thoroughly studied\u2014all of which lead to negative consequences like heart failure and left ventricular dysfunction. Cardiac magnetic resonance imaging along with coronary angiography and significant biomarkers like N-terminal proBNP and soluble ST2 aid in risk stratification and prognosis. In addition to mechanical techniques like ischemia postconditioning and remote ischemic conditioning, pharmacological treatments are also examined. Despite promising research findings, the majority of therapies have not yet proven consistently effective in extensive clinical studies. Consideration of sex-specific risk factors, medicines that target the mitochondria, tailored therapies, and the use of artificial intelligence for risk assessment and early diagnosis are some potential future avenues.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Reperfusion damage continues to be a significant obstacle to the best possible recovery after STEMI, even with improvements in revascularization. The management of STEMI still relies heavily on early reperfusion, although adjuvant medicines that target reperfusion injury specifically are desperately needed. Molecular-targeted approaches, AI-driven risk assessment, and precision medicine advancements have the potential to reduce cardiac damage and enhance long-term outcomes for patients with STEMI.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s43044-025-00683-7","type":"journal-article","created":{"date-parts":[[2025,9,5]],"date-time":"2025-09-05T07:45:28Z","timestamp":1757058328000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["Reperfusion injury in STEMI: a double-edged sword"],"prefix":"10.1186","volume":"77","author":[{"ORCID":"https:\/\/orcid.org\/0009-0003-9750-4415","authenticated-orcid":false,"given":"Krupa Sara","family":"Thomas","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-7438-8998","authenticated-orcid":false,"given":"Divina Mariya","family":"Puthooran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4857-4399","authenticated-orcid":false,"given":"Sudeep","family":"Edpuganti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-1601-9722","authenticated-orcid":false,"given":"Adi Lakshmi","family":"Reddem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-3426-7406","authenticated-orcid":false,"given":"Angela","family":"Jose","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-7210-0974","authenticated-orcid":false,"given":"Subramanya Sri Mahesh","family":"Akula","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,9,5]]},"reference":[{"issue":"43","key":"683_CR1","doi-asserted-by":"publisher","first-page":"e35687","DOI":"10.1097\/MD.0000000000035687","volume":"102","author":"C Elendu","year":"2023","unstructured":"Elendu C, Amaechi DC, Elendu TC, Omeludike EK, Alakwe-Ojimba CE, Obidigbo B et al (2023) Comprehensive review of ST-segment elevation myocardial infarction: understanding pathophysiology, diagnostic strategies, and current treatment approaches. Medicine (Baltimore) 102(43):e35687. https:\/\/doi.org\/10.1097\/MD.0000000000035687","journal-title":"Medicine (Baltimore)"},{"issue":"7","key":"683_CR2","doi-asserted-by":"publisher","first-page":"762","DOI":"10.1001\/jamacardio.2021.0676","volume":"6","author":"AJ Boyle","year":"2021","unstructured":"Boyle AJ, Schultz C, Selvanayagam JB, Moir S, Kovacs R, Dib N et al (2021) Calcium\/Calmodulin-dependent protein kinase II delta inhibition and ventricular remodeling after myocardial infarction: a randomized clinical trial. JAMA Cardiol 6(7):762\u2013768. https:\/\/doi.org\/10.1001\/jamacardio.2021.0676","journal-title":"JAMA Cardiol"},{"key":"683_CR3","unstructured":"Akbar H, Foth C, Kahloon RA, Mountfort S (2024) Acute ST-segment elevation myocardial infarction (STEMI). StatPearls. Available from: https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK532281\/"},{"issue":"12","key":"683_CR4","doi-asserted-by":"publisher","first-page":"398","DOI":"10.31083\/j.rcm2312398","volume":"23","author":"P Gao","year":"2022","unstructured":"Gao P, Zhang J, Fan X (2022) NHHR: an important independent risk factor for patients with STEMI. Rev Cardiovasc Med 23(12):398. https:\/\/doi.org\/10.31083\/j.rcm2312398","journal-title":"Rev Cardiovasc Med"},{"issue":"1","key":"683_CR5","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/j.jacasi.2023.09.013","volume":"4","author":"G Zhao","year":"2023","unstructured":"Zhao G, Zhou M, Zhao X, Ma C, Han Y, Liu J et al (2023) Characteristics, treatment, and in-hospital outcomes of older patients with STEMI without standard modifiable risk factors. JACC Asia 4(1):73\u201383. https:\/\/doi.org\/10.1016\/j.jacasi.2023.09.013","journal-title":"JACC Asia"},{"issue":"4","key":"683_CR6","doi-asserted-by":"publisher","first-page":"1650","DOI":"10.1159\/000489241","volume":"46","author":"MY Wu","year":"2018","unstructured":"Wu MY, Yiang GT, Liao WT, Tsai AP, Cheng YL, Cheng PW et al (2018) Current mechanistic concepts in ischemia and reperfusion injury. Cell Physiol Biochem 46(4):1650\u20131667. https:\/\/doi.org\/10.1159\/000489241","journal-title":"Cell Physiol Biochem"},{"issue":"1","key":"683_CR7","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1186\/s40360-024-00817-8","volume":"25","author":"M Geravandi","year":"2024","unstructured":"Geravandi M, Nourabi M, Navabifar S, Geravandi M, Hooshanginezhad Z, Zand S et al (2024) A comparison of the effects of ticagrelor and clopidogrel in patients with acute ST-segment elevation myocardial infarction: a systematic review and meta-analysis of randomized clinical trials. BMC Pharmacol Toxicol 25(1):93. https:\/\/doi.org\/10.1186\/s40360-024-00817-8","journal-title":"BMC Pharmacol Toxicol"},{"issue":"1","key":"683_CR8","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1186\/s13019-021-01524-9","volume":"16","author":"F Huang","year":"2021","unstructured":"Huang F, Mai J, Chen J, He Y, Chen X (2021) Non-coding RNAs modulate autophagy in myocardial ischemia-reperfusion injury: a systematic review. J Cardiothorac Surg 16(1):140. https:\/\/doi.org\/10.1186\/s13019-021-01524-9","journal-title":"J Cardiothorac Surg"},{"issue":"1","key":"683_CR9","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1038\/s41420-025-02372-5","volume":"11","author":"B Du","year":"2025","unstructured":"Du B, Fu Q, Yang Q, Yang Y, Li R, Yang X et al (2025) Different types of cell death and their interactions in myocardial ischemia-reperfusion injury. Cell Death Discov 11(1):87. https:\/\/doi.org\/10.1038\/s41420-025-02372-5","journal-title":"Cell Death Discov"},{"key":"683_CR10","doi-asserted-by":"publisher","first-page":"116629","DOI":"10.1016\/j.biopha.2024.116629","volume":"174","author":"T Li","year":"2024","unstructured":"Li T, Li Y, Zeng Y, Zhou X, Zhang S, Ren Y (2024) Construction of preclinical evidence for propofol in the treatment of reperfusion injury after acute myocardial infarction: a systematic review and meta-analysis. Biomed Pharmacother 174:116629. https:\/\/doi.org\/10.1016\/j.biopha.2024.116629","journal-title":"Biomed Pharmacother"},{"issue":"5","key":"683_CR11","doi-asserted-by":"publisher","first-page":"e0268330","DOI":"10.1371\/journal.pone.0268330","volume":"17","author":"M Canu","year":"2022","unstructured":"Canu M, Khouri C, Marliere S, Vautrin E, Piliero N, Ormezzano O et al (2022) Prognostic significance of severe coronary microvascular dysfunction post-PCI in patients with STEMI: a systematic review and meta-analysis. PLoS ONE 17(5):e0268330. https:\/\/doi.org\/10.1371\/journal.pone.0268330","journal-title":"PLoS ONE"},{"key":"683_CR12","doi-asserted-by":"publisher","first-page":"430","DOI":"10.3892\/etm.2022.11357","volume":"23","author":"J He","year":"2022","unstructured":"He J, Liu D, Zhao L, Zhou D, Rong J, Zhang L et al (2022) Myocardial ischemia\/reperfusion injury: mechanisms of injury and implications for management (Review). Exp Ther Med 23:430. https:\/\/doi.org\/10.3892\/etm.2022.11357","journal-title":"Exp Ther Med"},{"issue":"8","key":"683_CR13","doi-asserted-by":"publisher","first-page":"2233","DOI":"10.3390\/jcm11082233","volume":"11","author":"G Annibali","year":"2022","unstructured":"Annibali G, Scrocca I, Aranzulla TC, Meliga E, Maiellaro F, Musumeci G (2022) No-reflow phenomenon: a contemporary review. J Clin Med 11(8):2233. https:\/\/doi.org\/10.3390\/jcm11082233","journal-title":"J Clin Med"},{"key":"683_CR14","doi-asserted-by":"publisher","first-page":"1656450","DOI":"10.1155\/2016\/1656450","volume":"2016","author":"GA Kurian","year":"2016","unstructured":"Kurian GA, Rajagopal R, Vedantham S, Rajesh M (2016) The role of oxidative stress in myocardial ischemia and reperfusion injury and remodeling: revisited. Oxid Med Cell Longev 2016:1656450. https:\/\/doi.org\/10.1155\/2016\/1656450","journal-title":"Oxid Med Cell Longev"},{"key":"683_CR15","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.bioactmat.2021.06.006","volume":"7","author":"T Zhao","year":"2021","unstructured":"Zhao T, Wu W, Sui L, Huang Q, Nan Y, Liu J et al (2021) Reactive oxygen species-based nanomaterials for the treatment of myocardial ischemia reperfusion injuries. Bioact Mater 7:47\u201372. https:\/\/doi.org\/10.1016\/j.bioactmat.2021.06.006","journal-title":"Bioact Mater"},{"issue":"17","key":"683_CR16","doi-asserted-by":"publisher","first-page":"5592","DOI":"10.3390\/jcm12175592","volume":"12","author":"G Ndrepepa","year":"2023","unstructured":"Ndrepepa G, Kastrati A (2023) Coronary no-reflow after primary percutaneous coronary intervention\u2014current knowledge on pathophysiology, diagnosis, clinical impact and therapy. J Clin Med 12(17):5592. https:\/\/doi.org\/10.3390\/jcm12175592","journal-title":"J Clin Med"},{"issue":"11","key":"683_CR17","doi-asserted-by":"publisher","first-page":"774","DOI":"10.1093\/eurheartj\/ehw224","volume":"38","author":"G Heusch","year":"2017","unstructured":"Heusch G, Gersh BJ (2017) The pathophysiology of acute myocardial infarction and strategies of protection beyond reperfusion: a continual challenge. Eur Heart J 38(11):774\u2013784. https:\/\/doi.org\/10.1093\/eurheartj\/ehw224","journal-title":"Eur Heart J"},{"issue":"5","key":"683_CR18","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1097\/CRD.0000000000000440","volume":"31","author":"LM Buja","year":"2023","unstructured":"Buja LM (2023) Pathobiology of myocardial ischemia and reperfusion injury: models, modes, molecular mechanisms, modulation, and clinical applications. Cardiol Rev 31(5):252\u2013264. https:\/\/doi.org\/10.1097\/CRD.0000000000000440","journal-title":"Cardiol Rev"},{"key":"683_CR19","doi-asserted-by":"publisher","first-page":"8405370","DOI":"10.1155\/2020\/8405370","volume":"2020","author":"CD S\u00e1nchez-Hern\u00e1ndez","year":"2020","unstructured":"S\u00e1nchez-Hern\u00e1ndez CD, Torres-Alarc\u00f3n LA, Gonz\u00e1lez-Cort\u00e9s A, Pe\u00f3n AN (2020) Ischemia\/reperfusion injury: pathophysiology, current clinical management, and potential preventive approaches. Mediators Inflamm 2020:8405370. https:\/\/doi.org\/10.1155\/2020\/8405370","journal-title":"Mediators Inflamm"},{"issue":"6","key":"683_CR20","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1016\/j.tcm.2022.02.005","volume":"33","author":"M Algoet","year":"2023","unstructured":"Algoet M, Janssens S, Himmelreich U, Gsell W, Pusovnik M, Van den Eynde J, Oosterlinck W (2023) Myocardial ischemia-reperfusion injury and the influence of inflammation. Trends Cardiovasc Med 33(6):357\u2013366. https:\/\/doi.org\/10.1016\/j.tcm.2022.02.005","journal-title":"Trends Cardiovasc Med"},{"issue":"12","key":"683_CR21","doi-asserted-by":"publisher","first-page":"101398","DOI":"10.1016\/j.cpcardiol.2022.101398","volume":"47","author":"A Sch\u00e4fer","year":"2022","unstructured":"Sch\u00e4fer A, K\u00f6nig T, Bauersachs J, Akin M (2022) Novel therapeutic strategies to reduce reperfusion injury after acute myocardial infarction. Curr Probl Cardiol 47(12):101398. https:\/\/doi.org\/10.1016\/j.cpcardiol.2022.101398","journal-title":"Curr Probl Cardiol"},{"key":"683_CR22","doi-asserted-by":"publisher","first-page":"183469","DOI":"10.1155\/2015\/183469","volume":"2015","author":"KL Go","year":"2015","unstructured":"Go KL, Lee S, Zendejas I, Behrns KE, Kim JS (2015) Mitochondrial dysfunction and autophagy in hepatic ischemia\/reperfusion injury. Biomed Res Int 2015:183469. https:\/\/doi.org\/10.1155\/2015\/183469","journal-title":"Biomed Res Int"},{"key":"683_CR23","doi-asserted-by":"publisher","first-page":"105986","DOI":"10.1016\/j.phrs.2021.105986","volume":"175","author":"AR Bland","year":"2022","unstructured":"Bland AR, Payne FM, Ashton JC, Jamialahmadi T, Sahebkar A (2022) The cardioprotective actions of statins in targeting mitochondrial dysfunction associated with myocardial ischaemia\u2013reperfusion injury. Pharmacol Res 175:105986. https:\/\/doi.org\/10.1016\/j.phrs.2021.105986","journal-title":"Pharmacol Res"},{"issue":"2","key":"683_CR24","doi-asserted-by":"publisher","first-page":"199","DOI":"10.3390\/cells11020199","volume":"11","author":"A Turkieh","year":"2022","unstructured":"Turkieh A, El Masri Y, Pinet F, Dubois-Deruy E (2022) Mitophagy regulation following myocardial infarction. Cells 11(2):199. https:\/\/doi.org\/10.3390\/cells11020199","journal-title":"Cells"},{"issue":"4","key":"683_CR25","doi-asserted-by":"publisher","first-page":"e62400","DOI":"10.1371\/journal.pone.0062400","volume":"8","author":"HK Siddall","year":"2013","unstructured":"Siddall HK, Yellon DM, Ong S, Mukherjee UA, Burke N, Hall AR, Hausenloy DJ (2013) Loss of PINK1 increases the heart\u2019s vulnerability to ischemia\u2013reperfusion injury. PLoS ONE 8(4):e62400. https:\/\/doi.org\/10.1371\/journal.pone.0062400","journal-title":"PLoS ONE"},{"issue":"12","key":"683_CR26","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1038\/s41569-020-0403-y","volume":"17","author":"G Heusch","year":"2020","unstructured":"Heusch G (2020) Myocardial ischaemia\u2013reperfusion injury and cardioprotection in perspective. Nat Rev Cardiol 17(12):773\u2013789. https:\/\/doi.org\/10.1038\/s41569-020-0403-y","journal-title":"Nat Rev Cardiol"},{"key":"683_CR27","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1038\/s41420-025-02328-9","volume":"11","author":"G Eskander","year":"2025","unstructured":"Eskander G, Abdelhamid SG, Wahdan SA et al (2025) Insights on the crosstalk among different cell death mechanisms. Cell Death Discov 11:56. https:\/\/doi.org\/10.1038\/s41420-025-02328-9","journal-title":"Cell Death Discov"},{"issue":"1","key":"683_CR28","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1515\/jtim-2025-0004","volume":"13","author":"Z Guo","year":"2025","unstructured":"Guo Z, Liu Y, Chen D, Sun Y, Li D, Meng Y, Zhou Q, Zeng F, Deng G, Chen X (2025) Targeting regulated cell death: apoptosis, necroptosis, pyroptosis, ferroptosis, and cuproptosis in anticancer immunity. J Transl Intern Med 13(1):10\u201332. https:\/\/doi.org\/10.1515\/jtim-2025-0004","journal-title":"J Transl Intern Med"},{"issue":"4","key":"683_CR29","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1007\/s12265-023-10372-y","volume":"16","author":"T Koyama","year":"2023","unstructured":"Koyama T (2023) Postconditioning with lactate-enriched blood for reducing lethal reperfusion injury in humans. J Cardiovasc Transl Res 16(4):793\u2013802. https:\/\/doi.org\/10.1007\/s12265-023-10372-y","journal-title":"J Cardiovasc Transl Res"},{"issue":"4","key":"683_CR30","doi-asserted-by":"publisher","first-page":"802","DOI":"10.3390\/biomedicines12040802","volume":"12","author":"M Sagris","year":"2024","unstructured":"Sagris M, Apostolos A, Theofilis P, Ktenopoulos N, Katsaros O, Tsalamandris S et al (2024) Myocardial ischemia\u2013reperfusion injury: unraveling pathophysiology, clinical manifestations, and emerging prevention strategies. Biomedicines 12(4):802. https:\/\/doi.org\/10.3390\/biomedicines12040802","journal-title":"Biomedicines"},{"issue":"18","key":"683_CR31","doi-asserted-by":"publisher","first-page":"5390","DOI":"10.3390\/jcm13185390","volume":"13","author":"N Pyrpyris","year":"2024","unstructured":"Pyrpyris N, Dimitriadis K, Iliakis P, Theofilis P, Beneki E, Terentes-Printzios D, Sakalidis A, Antonopoulos A, Aznaouridis K, Tsioufis K (2024) Hypothermia for cardioprotection in acute coronary syndrome patients: from bench to bedside. J Clin Med 13(18):5390. https:\/\/doi.org\/10.3390\/jcm13185390","journal-title":"J Clin Med"},{"issue":"4","key":"683_CR32","doi-asserted-by":"publisher","first-page":"209","DOI":"10.4103\/tcmj.tcmj_33_18","volume":"30","author":"CF Yang","year":"2018","unstructured":"Yang CF (2018) Clinical manifestations and basic mechanisms of myocardial ischemia\/reperfusion injury. Tzu Chi Med J 30(4):209\u2013215. https:\/\/doi.org\/10.4103\/tcmj.tcmj_33_18","journal-title":"Tzu Chi Med J"},{"issue":"4","key":"683_CR33","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1016\/j.ihj.2016.04.006","volume":"68","author":"S Gupta","year":"2016","unstructured":"Gupta S, Gupta MM (2016) No reflow phenomenon in percutaneous coronary interventions in ST-segment elevation myocardial infarction. Indian Heart J 68(4):539\u2013551. https:\/\/doi.org\/10.1016\/j.ihj.2016.04.006","journal-title":"Indian Heart J"},{"issue":"5","key":"683_CR34","doi-asserted-by":"publisher","first-page":"382","DOI":"10.5152\/AnatolJCardiol.2021.846","volume":"26","author":"M Khalfallah","year":"2022","unstructured":"Khalfallah M, Allaithy A, Maria DA (2022) Impact of the total ischemia time on no-reflow phenomenon in patients with ST elevation myocardial infarction undergoing primary percutaneous coronary intervention. Anatol J Cardiol 26(5):382\u2013387. https:\/\/doi.org\/10.5152\/AnatolJCardiol.2021.846","journal-title":"Anatol J Cardiol"},{"issue":"10","key":"683_CR35","doi-asserted-by":"publisher","first-page":"5168","DOI":"10.62347\/SUQT4991","volume":"16","author":"L Yu","year":"2024","unstructured":"Yu L, Chen J, Zhang J (2024) Meta-analysis of the correlation between inflammatory response indices and no-reflow after PCI in patients with acute STEMI. Am J Transl Res 16(10):5168\u20135181. https:\/\/doi.org\/10.62347\/SUQT4991","journal-title":"Am J Transl Res"},{"issue":"2","key":"683_CR36","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1016\/j.ihj.2023.02.002","volume":"75","author":"S Rao","year":"2023","unstructured":"Rao S, Bhardwaj R, Negi PC, Nath RK (2023) No reflow phenomenon in CAD patients after percutaneous coronary intervention: a prospective hospital based observational study. Indian Heart J 75(2):156\u2013159. https:\/\/doi.org\/10.1016\/j.ihj.2023.02.002","journal-title":"Indian Heart J"},{"key":"683_CR37","doi-asserted-by":"publisher","first-page":"608193","DOI":"10.3389\/fcvm.2020.608193","volume":"7","author":"LB Szapary","year":"2021","unstructured":"Szapary LB, Szakacs Z, Farkas N, Schonfeld K, Babocsay D, Gajer M et al (2021) The effect of Magnesium on reperfusion arrhythmias in STEMI patients, treated with PPCI. a systematic review with a meta-analysis and trial sequential analysis. Front Cardiovasc Med 7:608193. https:\/\/doi.org\/10.3389\/fcvm.2020.608193","journal-title":"Front Cardiovasc Med"},{"issue":"1","key":"683_CR38","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1186\/s12872-025-04953-9","volume":"25","author":"X Wu","year":"2025","unstructured":"Wu X, Wu M, Huang H, Liu Z, Huang H, Wang L (2025) Incidence, predictors, and prognostic impact of reperfusion-related ventricular arrhythmias in STEMI patients undergoing primary percutaneous coronary intervention. BMC Cardiovasc Disord 25(1):494. https:\/\/doi.org\/10.1186\/s12872-025-04953-9","journal-title":"BMC Cardiovasc Disord"},{"issue":"6","key":"683_CR39","doi-asserted-by":"publisher","first-page":"100444","DOI":"10.1016\/j.jscai.2022.100444","volume":"1","author":"R Vyas","year":"2022","unstructured":"Vyas R, Changal KH, Bhuta S, Pasadyn V, Katterle K, Niedoba MJ et al (2022) Impact of intramyocardial hemorrhage on clinical outcomes in ST-elevation myocardial infarction: a systematic review and meta-analysis. J Soc Cardiovasc Angiogr Interv 1(6):100444. https:\/\/doi.org\/10.1016\/j.jscai.2022.100444","journal-title":"J Soc Cardiovasc Angiogr Interv"},{"issue":"1","key":"683_CR40","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.jacc.2021.10.034","volume":"79","author":"T Liu","year":"2022","unstructured":"Liu T, Howarth AG, Chen Y, Nair AR, Yang HJ, Ren D et al (2022) Intramyocardial hemorrhage and the \u201cWave Front\u201d of reperfusion injury compromising myocardial salvage. J Am Coll Cardiol 79(1):35\u201348. https:\/\/doi.org\/10.1016\/j.jacc.2021.10.034","journal-title":"J Am Coll Cardiol"},{"key":"683_CR41","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-022-24019-6","author":"X Wang","year":"2022","unstructured":"Wang X, Li B, Hu Y, Xiao S, Guo M, Xu T et al (2022) Novel grading system for ischemia\u2013reperfusion injury manifestations in patients with acute ST-segment elevation myocardial infarction undergoing percutaneous coronary intervention. Sci Rep. https:\/\/doi.org\/10.1038\/s41598-022-24019-6","journal-title":"Sci Rep"},{"key":"683_CR42","doi-asserted-by":"publisher","first-page":"891047","DOI":"10.3389\/fsurg.2022.891047","volume":"9","author":"L Zhang","year":"2022","unstructured":"Zhang L, Wang L, Tao L, Chen C, Ren S, Zhang Y (2022) Risk factors of ischemia reperfusion injury after PCI in patients with acute ST-segment elevation myocardial infarction and its influence on prognosis. Front Surg 9:891047. https:\/\/doi.org\/10.3389\/fsurg.2022.891047","journal-title":"Front Surg"},{"issue":"1","key":"683_CR43","doi-asserted-by":"publisher","first-page":"9484","DOI":"10.1038\/s41598-025-94528-7","volume":"15","author":"Z Zhou","year":"2025","unstructured":"Zhou Z, Chen Q, Zhang Z, Wang T, Zhao Y, Chen W et al (2025) Early prediction of microvascular obstruction prior to percutaneous coronary intervention. Sci Rep 15(1):9484. https:\/\/doi.org\/10.1038\/s41598-025-94528-7","journal-title":"Sci Rep"},{"issue":"13","key":"683_CR44","doi-asserted-by":"publisher","first-page":"935","DOI":"10.1093\/eurheartj\/ehw145","volume":"38","author":"DJ Hausenloy","year":"2017","unstructured":"Hausenloy DJ, Botker HE, Engstrom T, Erlinge D, Heusch G, Ibanez B et al (2017) Targeting reperfusion injury in patients with ST-segment elevation myocardial infarction: trials and tribulations. Eur Heart J 38(13):935\u2013941. https:\/\/doi.org\/10.1093\/eurheartj\/ehw145","journal-title":"Eur Heart J"},{"key":"683_CR45","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCIMAGING.124.017645","author":"F Troger","year":"2025","unstructured":"Troger F, Pamminger M, Poskaite P, Reindl M, Holzknecht M, Lechner I et al (2025) Clinical impact of persistent microvascular obstruction in CMR after reperfused STEMI. Circ Cardiovasc Imaging. https:\/\/doi.org\/10.1161\/CIRCIMAGING.124.017645","journal-title":"Circ Cardiovasc Imaging"},{"issue":"4","key":"683_CR46","doi-asserted-by":"publisher","first-page":"e37698","DOI":"10.7759\/cureus.37698","volume":"15","author":"BS Hilabi","year":"2023","unstructured":"Hilabi BS, Alghamdi SA, Almanaa M (2023) Impact of magnetic resonance imaging on healthcare in low- and middle-income countries. Cureus 15(4):e37698. https:\/\/doi.org\/10.7759\/cureus.37698","journal-title":"Cureus"},{"issue":"4","key":"683_CR47","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1007\/s13244-016-0494-5","volume":"7","author":"H Chalian","year":"2016","unstructured":"Chalian H, O\u2019Donnell JK, Bolen M, Rajiah P (2016) Incremental value of PET and MRI in the evaluation of cardiovascular abnormalities. Insights Imaging 7(4):485\u2013503. https:\/\/doi.org\/10.1007\/s13244-016-0494-5","journal-title":"Insights Imaging"},{"key":"683_CR48","unstructured":"Ghadimi M, Thomas A (2025) Magnetic resonance imaging contraindications. [Updated 2025 May 4]. In: StatPearls [Internet]. StatPearls Publishing: Treasure Island (FL). Available from: https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK551669\/"},{"issue":"4","key":"683_CR49","doi-asserted-by":"publisher","first-page":"1649","DOI":"10.1007\/s11845-022-03210-8","volume":"192","author":"B Brady","year":"2023","unstructured":"Brady B, King G, Murphy RT, Walsh D (2023) Myocardial strain: a clinical review. Ir J Med Sci 192(4):1649\u20131656. https:\/\/doi.org\/10.1007\/s11845-022-03210-8","journal-title":"Ir J Med Sci"},{"issue":"1","key":"683_CR50","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1007\/s00380-022-02131-x","volume":"38","author":"Z Lu","year":"2023","unstructured":"Lu Z, Liu T, Wang C et al (2023) The evaluation of coronary microvascular obstruction in patients with STEMI by cardiac magnetic resonance T2-STIR image and layer-specific analysis of 2-dimensional speckle tracking echocardiography combined with low-dose dobutamine stress echocardiography. Heart Vessels 38(1):40\u201348. https:\/\/doi.org\/10.1007\/s00380-022-02131-x","journal-title":"Heart Vessels"},{"key":"683_CR51","unstructured":"Ashley EA, Niebauer J (2004). Cardiology explained. Remedica, London. Chapter 4, Understanding the echocardiogram. Available from: https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK2215\/"},{"issue":"4","key":"683_CR52","doi-asserted-by":"publisher","first-page":"e016517","DOI":"10.1161\/CIRCIMAGING.124.016517","volume":"17","author":"LD Gillam","year":"2024","unstructured":"Gillam LD, Marcoff L (2024) Echocardiography: past, present, and future. Circ Cardiovasc Imaging 17(4):e016517. https:\/\/doi.org\/10.1161\/CIRCIMAGING.124.016517","journal-title":"Circ Cardiovasc Imaging"},{"key":"683_CR53","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1016\/j.amjcard.2024.02.022","volume":"217","author":"M Celeski","year":"2024","unstructured":"Celeski M, Segreti A, Polito D, Valente D, Vicchio L, Di Gioia G, Ussia GP, Antonelli Incalzi R, Grigioni F (2024) Traditional and advanced echocardiographic evaluation in chronic obstructive pulmonary disease: the forgotten relation. Am J Cardiol 217:102\u2013118. https:\/\/doi.org\/10.1016\/j.amjcard.2024.02.022","journal-title":"Am J Cardiol"},{"issue":"2","key":"683_CR54","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1016\/j.jemermed.2015.07.023","volume":"50","author":"SD Siadecki","year":"2016","unstructured":"Siadecki SD, Frasure SE, Lewiss RE, Saul T (2016) High body mass index is strongly correlated with decreased image quality in focused bedside echocardiography. J Emerg Med 50(2):295\u2013301. https:\/\/doi.org\/10.1016\/j.jemermed.2015.07.023","journal-title":"J Emerg Med"},{"key":"683_CR55","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1038\/s41597-025-04727-0","volume":"12","author":"SS Mahmoudi","year":"2025","unstructured":"Mahmoudi SS, Alishani MM, Emdadi M et al (2025) X-ray coronary angiogram images and SYNTAX score to develop machine-learning algorithms for CHD diagnosis. Sci Data 12:471. https:\/\/doi.org\/10.1038\/s41597-025-04727-0","journal-title":"Sci Data"},{"key":"#cr-split#-683_CR56.1","unstructured":"Sarkar A, Grigg WS, Lee JJ (2025) TIMI grade flow. In: StatPearls [Internet]. StatPearls Publishing: Treasure Island (FL) (Updated 2023 Apr 24"},{"key":"#cr-split#-683_CR56.2","unstructured":"cited 2025 Aug 14). Available from: https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK482412\/"},{"issue":"5","key":"683_CR57","doi-asserted-by":"publisher","first-page":"e017506","DOI":"10.1161\/CIRCIMAGING.124.017506","volume":"18","author":"G Lu","year":"2025","unstructured":"Lu G, Zhao L, Hui K et al (2025) Angiography-derived microcirculatory resistance in detecting microvascular obstruction and predicting heart failure after STEMI. Circ Cardiovasc Imaging 18(5):e017506. https:\/\/doi.org\/10.1161\/CIRCIMAGING.124.017506","journal-title":"Circ Cardiovasc Imaging"},{"issue":"4","key":"683_CR58","doi-asserted-by":"publisher","first-page":"990","DOI":"10.1148\/rg.2021200125","volume":"41","author":"A Sirajuddin","year":"2021","unstructured":"Sirajuddin A, Mirmomen SM, Kligerman SJ, Groves DW, Burke AP, Kureshi F, White CS, Arai AE (2021) Ischemic heart disease: Noninvasive imaging techniques and findings. Radiographics 41(4):990\u20131021. https:\/\/doi.org\/10.1148\/rg.2021200125","journal-title":"Radiographics"},{"key":"#cr-split#-683_CR59.1","unstructured":"Ramjattan NA, Lala V, Kousa O et al. (2025) Coronary CT angiography. In: StatPearls [Internet]. StatPearls Publishing: Treasure Island (FL) (Updated 2024 Jan 19"},{"key":"#cr-split#-683_CR59.2","unstructured":"cited 2025 Aug 14). Available from: https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK470279\/"},{"key":"683_CR60","doi-asserted-by":"publisher","first-page":"9322460","DOI":"10.1155\/2022\/9322460","volume":"2022","author":"SM Chang","year":"2022","unstructured":"Chang SM, Yu YT, Luan B, Hou AJ, Wang Y (2022) Predictive value of soluble growth stimulator gene 2 protein for coronary slow flow\/no-reflow in ST-elevation myocardial infarction patients receiving percutaneous coronary intervention. J Interv Cardiol 2022:9322460. https:\/\/doi.org\/10.1155\/2022\/9322460","journal-title":"J Interv Cardiol"},{"issue":"2","key":"683_CR61","doi-asserted-by":"publisher","first-page":"270","DOI":"10.3390\/jcm8020270","volume":"8","author":"A Aleksova","year":"2019","unstructured":"Aleksova A, Paldino A, Beltrami AP, Padoan L, Iacoviello M, Sinagra G, Emdin M, Maisel AS (2019) Cardiac biomarkers in the emergency department: the role of soluble ST2 (sST2) in acute heart failure and acute coronary syndrome\u2014there is meat on the bone. J Clin Med 8(2):270. https:\/\/doi.org\/10.3390\/jcm8020270","journal-title":"J Clin Med"},{"key":"683_CR62","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1186\/s12872-025-04488-z","volume":"25","author":"S Huang","year":"2025","unstructured":"Huang S, Yu LJ, Sun GF et al (2025) Short-term predictive value of sST2 in patients with STEMI following primary PCI: a prospective observational study. BMC Cardiovasc Disord 25:21. https:\/\/doi.org\/10.1186\/s12872-025-04488-z","journal-title":"BMC Cardiovasc Disord"},{"key":"683_CR63","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1186\/s12872-025-04708-6","volume":"25","author":"W Che","year":"2025","unstructured":"Che W, Jin Y, Chang S et al (2025) Prediction of myocardial ischemia\u2013reperfusion injury post-PCI: role of sST2 levels in STEMI patients. BMC Cardiovasc Disord 25:280. https:\/\/doi.org\/10.1186\/s12872-025-04708-6","journal-title":"BMC Cardiovasc Disord"},{"key":"683_CR64","doi-asserted-by":"publisher","first-page":"3348","DOI":"10.3390\/diagnostics13213348","volume":"13","author":"RM Vucic","year":"2023","unstructured":"Vucic RM, Andrejic OM, Stokanovic D, Stoimenov TJ, McClements L, Nikolic VN et al (2023) Galectin-3 as a prognostic biomarker in patients with first acute myocardial infarction without heart failure. Diagnostics 13:3348. https:\/\/doi.org\/10.3390\/diagnostics13213348","journal-title":"Diagnostics"},{"issue":"18","key":"683_CR65","doi-asserted-by":"publisher","first-page":"2286","DOI":"10.1016\/j.jacc.2019.02.046","volume":"73","author":"R Asleh","year":"2019","unstructured":"Asleh R, Enriquez-Sarano M, Jaffe AS, Manemann SM, Weston SA, Jiang R, Roger VL (2019) Galectin-3 levels and outcomes after myocardial infarction: a population-based study. J Am Coll Cardiol 73(18):2286\u20132295. https:\/\/doi.org\/10.1016\/j.jacc.2019.02.046","journal-title":"J Am Coll Cardiol"},{"key":"683_CR66","doi-asserted-by":"publisher","first-page":"9529053","DOI":"10.1155\/2019\/9529053","volume":"2019","author":"A Tymi\u0144ska","year":"2019","unstructured":"Tymi\u0144ska A, Kap\u0142on-Cie\u015blicka A, Oziera\u0144ski K, Budnik M, Wancerz A, Sypie\u0144 P, Peller M, Balsam P, Opolski G, Filipiak KJ (2019) Association of galectin-3 and soluble ST2, and their changes, with echocardiographic parameters and development of heart failure after ST-segment elevation myocardial infarction. Dis Markers 2019:9529053. https:\/\/doi.org\/10.1155\/2019\/9529053","journal-title":"Dis Markers"},{"issue":"17","key":"683_CR67","doi-asserted-by":"publisher","first-page":"2193","DOI":"10.1016\/j.jacc.2019.08.1039","volume":"74","author":"A Aimo","year":"2019","unstructured":"Aimo A, Januzzi JL, Bayes-Genis A, Vergaro G, Sciarrone P, Passino C, Emdin M (2019) Clinical and prognostic significance of sST2 in heart failure: JACC review topic of the week. J Am Coll Cardiol 74(17):2193\u20132203. https:\/\/doi.org\/10.1016\/j.jacc.2019.08.1039","journal-title":"J Am Coll Cardiol"},{"issue":"8","key":"683_CR68","doi-asserted-by":"publisher","first-page":"1010","DOI":"10.3390\/diagnostics15081010","volume":"15","author":"F Davini","year":"2025","unstructured":"Davini F, Fogolari M, D\u2019Avanzo G, Ristori MV, Nucciarelli S, Bani L et al (2025) Soluble suppression of tumorigenicity 2 (sST2) as a diagnostic and prognostic marker in acute heart failure and sepsis: a comparative analysis. Diagnostics 15(8):1010. https:\/\/doi.org\/10.3390\/diagnostics15081010","journal-title":"Diagnostics"},{"issue":"5","key":"683_CR69","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1016\/j.cardfail.2023.02.009","volume":"29","author":"H Tsutsui","year":"2023","unstructured":"Tsutsui H, Albert NM, Coats AJS, Anker SD, Bayes-Genis A, Butler J et al (2023) Natriuretic peptides: role in the diagnosis and management of heart failure: a scientific statement from the Heart Failure Association of the European Society of Cardiology, Heart Failure Society of America and Japanese Heart Failure Society. J Card Fail 29(5):787\u2013804. https:\/\/doi.org\/10.1016\/j.cardfail.2023.02.009","journal-title":"J Card Fail"},{"issue":"8","key":"683_CR70","doi-asserted-by":"publisher","first-page":"1820","DOI":"10.3390\/ijms20081820","volume":"20","author":"Z Cao","year":"2019","unstructured":"Cao Z, Jia Y, Zhu B (2019) BNP and NT-proBNP as diagnostic biomarkers for cardiac dysfunction in both clinical and forensic medicine. Int J Mol Sci 20(8):1820. https:\/\/doi.org\/10.3390\/ijms20081820","journal-title":"Int J Mol Sci"},{"issue":"3","key":"683_CR71","doi-asserted-by":"publisher","first-page":"305","DOI":"10.11909\/j.issn.1671-5411.2015.03.020","volume":"12","author":"L Fang","year":"2015","unstructured":"Fang L, Moore XL, Dart AM, Wang LM (2015) Systemic inflammatory response following acute myocardial infarction. J Geriatr Cardiol 12(3):305\u2013312. https:\/\/doi.org\/10.11909\/j.issn.1671-5411.2015.03.020","journal-title":"J Geriatr Cardiol"},{"key":"#cr-split#-683_CR72.1","unstructured":"Singh B, Goyal A, Patel BC (2025) C-reactive protein: clinical relevance and interpretation. In: StatPearls. StatPearls Publishing: Treasure Island"},{"key":"#cr-split#-683_CR72.2","unstructured":"(FL) (updated 2025 May 3). Available from: https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK441843\/"},{"issue":"4","key":"683_CR73","doi-asserted-by":"publisher","first-page":"100866","DOI":"10.1016\/j.jacadv.2024.100866","volume":"3","author":"DD Berg","year":"2024","unstructured":"Berg DD, O\u2019Donoghue ML, Jarolim P, Guo J, Sabatine MS, Morrow DA (2024) Biomarkers in the IL-6 pathway and cardiovascular outcomes in patients with STEMI in LATITUDE-TIMI 60. JACC Adv 3(4):100866. https:\/\/doi.org\/10.1016\/j.jacadv.2024.100866","journal-title":"JACC Adv"},{"issue":"1","key":"683_CR74","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1007\/s11883-024-01259-7","volume":"27","author":"NN Mehta","year":"2024","unstructured":"Mehta NN, de Goma E, Shapiro MD (2024) IL-6 and cardiovascular risk: a narrative review. Curr Atheroscler Rep 27(1):12. https:\/\/doi.org\/10.1007\/s11883-024-01259-7","journal-title":"Curr Atheroscler Rep"},{"issue":"9","key":"683_CR75","doi-asserted-by":"publisher","first-page":"1260","DOI":"10.1161\/CIRCRESAHA.120.315937","volume":"126","author":"A Abbate","year":"2020","unstructured":"Abbate A, Toldo S, Marchetti C, Kron J, Van Tassell BW, Dinarello CA (2020) Interleukin-1 and the inflammasome as therapeutic targets in cardiovascular disease. Circ Res 126(9):1260\u20131280. https:\/\/doi.org\/10.1161\/CIRCRESAHA.120.315937","journal-title":"Circ Res"},{"key":"683_CR76","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1186\/s12872-025-04953-9","volume":"25","author":"X Wu","year":"2025","unstructured":"Wu X, Wu M, Huang H et al (2025) Incidence, predictors, and prognostic impact of reperfusion-related ventricular arrhythmias in STEMI patients undergoing primary percutaneous coronary intervention. BMC Cardiovasc Disord 25:494. https:\/\/doi.org\/10.1186\/s12872-025-04953-9","journal-title":"BMC Cardiovasc Disord"},{"key":"683_CR77","doi-asserted-by":"publisher","first-page":"275","DOI":"10.2147\/IJGM.S444360","volume":"17","author":"Z Wu","year":"2024","unstructured":"Wu Z, Jin X, Tudahun I, Wu S, Chen M, Tang J (2024) Intramyocardial hemorrhage leads to higher MACE rate by increasing myocardial infarction volume in patients with STEMI. Int J Gen Med 17:275\u2013285. https:\/\/doi.org\/10.2147\/IJGM.S444360","journal-title":"Int J Gen Med"},{"issue":"7","key":"683_CR78","doi-asserted-by":"publisher","first-page":"1006","DOI":"10.1007\/s00392-023-02340-y","volume":"113","author":"G Ndrepepa","year":"2024","unstructured":"Ndrepepa G, Cassese S, Xhepa E et al (2024) Coronary no-reflow and adverse events in patients with acute myocardial infarction after percutaneous coronary intervention with current drug-eluting stents and third-generation P2Y12 inhibitors. Clin Res Cardiol 113(7):1006\u20131016. https:\/\/doi.org\/10.1007\/s00392-023-02340-y","journal-title":"Clin Res Cardiol"},{"key":"683_CR79","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1007\/s00395-018-0672-3","volume":"113","author":"A Gaspar","year":"2018","unstructured":"Gaspar A, Louren\u00e7o AP, Pereira M\u00c1 et al (2018) Randomized controlled trial of remote ischaemic conditioning in ST-elevation myocardial infarction as adjuvant to primary angioplasty (RIC-STEMI). Basic Res Cardiol 113:14. https:\/\/doi.org\/10.1007\/s00395-018-0672-3","journal-title":"Basic Res Cardiol"},{"issue":"10207","key":"683_CR80","doi-asserted-by":"publisher","first-page":"1415","DOI":"10.1016\/S0140-6736(19)32039-2","volume":"394","author":"DJ Hausenloy","year":"2019","unstructured":"Hausenloy DJ, Kharbanda RK, M\u00f8ller UK et al (2019) Effect of remote ischaemic conditioning on clinical outcomes in patients with acute myocardial infarction (CONDI-2\/ERIC-PPCI): a single-blind randomised controlled trial. Lancet 394(10207):1415\u20131424. https:\/\/doi.org\/10.1016\/S0140-6736(19)32039-2","journal-title":"Lancet"},{"issue":"6","key":"683_CR81","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1177\/1074248420937871","volume":"25","author":"HE B\u00f8tker","year":"2020","unstructured":"B\u00f8tker HE (2020) The future of cardioprotection\u2014pointing toward patients at elevated risk as the target populations. J Cardiovasc Pharmacol Ther 25(6):487\u2013493. https:\/\/doi.org\/10.1177\/1074248420937871","journal-title":"J Cardiovasc Pharmacol Ther"},{"key":"683_CR82","doi-asserted-by":"publisher","first-page":"3049","DOI":"10.1093\/eurheartj\/ehv463","volume":"36","author":"I Eitel","year":"2015","unstructured":"Eitel I, Stiermaier T, Rommel KP, Fuernau G, Sandri M, Mangner N et al (2015) Cardioprotection by combined intrahospital remote ischaemic perconditioning and postconditioning in ST-elevation myocardial infarction: the randomized LIPSIA conditioning trial. Eur Heart J 36:3049\u20133057. https:\/\/doi.org\/10.1093\/eurheartj\/ehv463","journal-title":"Eur Heart J"},{"key":"683_CR83","unstructured":"ClinicalTrials.gov. CARIOCA: combined effect of remote ischemic perconditioning and ischemic postconditioning in STEMI patients undergoing primary PCI. Identifier NCT03155022. Available from: https:\/\/clinicaltrials.gov\/study\/NCT03155022"},{"issue":"18","key":"683_CR84","doi-asserted-by":"publisher","first-page":"1857","DOI":"10.1016\/j.jacc.2013.12.027","volume":"63","author":"D Erlinge","year":"2014","unstructured":"Erlinge D, G\u00f6tberg M, Lang I, Holzer M, Noc M, Clemmensen P et al (2014) Rapid endovascular catheter core cooling combined with cold saline as an adjunct to percutaneous coronary intervention for the treatment of acute myocardial infarction: the CHILL-MI trial. J Am Coll Cardiol 63(18):1857\u20131865. https:\/\/doi.org\/10.1016\/j.jacc.2013.12.027","journal-title":"J Am Coll Cardiol"},{"issue":"4","key":"683_CR85","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1097\/FJC.0000000000000980","volume":"77","author":"H Kakavand","year":"2021","unstructured":"Kakavand H, Aghakouchakzadeh M, Coons JC, Talasaz AH (2021) Pharmacologic prevention of myocardial ischemia-reperfusion injury in patients with acute coronary syndrome undergoing percutaneous coronary intervention. J Cardiovasc Pharmacol 77(4):430\u2013449. https:\/\/doi.org\/10.1097\/FJC.0000000000000980","journal-title":"J Cardiovasc Pharmacol"},{"issue":"10","key":"683_CR86","doi-asserted-by":"publisher","first-page":"894","DOI":"10.1161\/CIRCULATIONAHA.117.027575","volume":"136","author":"S Pasupathy","year":"2017","unstructured":"Pasupathy S, Tavella R, Grover S, Raman B, Procter NEK, Du YT et al (2017) Early use of N-acetylcysteine with nitrate therapy in patients undergoing primary percutaneous coronary intervention for ST-segment-elevation myocardial infarction reduces myocardial infarct size (the NACIAM trial). Circulation 136(10):894\u2013903. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.117.027575","journal-title":"Circulation"},{"issue":"3","key":"683_CR87","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1007\/s40256-017-0258-8","volume":"18","author":"Y Nozari","year":"2018","unstructured":"Nozari Y, Eshraghi A, Talasaz AH, Bahremand M, Salamzadeh J, Salarifar M et al (2018) Protection from reperfusion injury with intracoronary N-acetylcysteine in patients with STEMI undergoing primary percutaneous coronary intervention in a cardiac tertiary center. Am J Cardiovasc Drugs 18(3):213\u2013221. https:\/\/doi.org\/10.1007\/s40256-017-0258-8","journal-title":"Am J Cardiovasc Drugs"},{"issue":"18","key":"683_CR88","doi-asserted-by":"publisher","first-page":"5702","DOI":"10.3390\/molecules26185702","volume":"26","author":"R Rodrigo","year":"2021","unstructured":"Rodrigo R, Prieto JC, Aguayo R, Ramos C, Puentes \u00c1, Gajardo A et al (2021) Joint cardioprotective effect of vitamin C and other antioxidants against reperfusion injury in patients with acute myocardial infarction undergoing percutaneous coronary intervention. Molecules 26(18):5702. https:\/\/doi.org\/10.3390\/molecules26185702","journal-title":"Molecules"},{"issue":"2","key":"683_CR89","doi-asserted-by":"publisher","first-page":"EVIDoa2300286","DOI":"10.1056\/EVIDoa2300286","volume":"3","author":"S James","year":"2024","unstructured":"James S, Erlinge D, Storey RF, McGuire DK, de Belder M, Eriksson N et al (2024) Dapagliflozin in myocardial infarction without diabetes or heart failure. NEJM Evid. 3(2):EVIDoa2300286. https:\/\/doi.org\/10.1056\/EVIDoa2300286","journal-title":"NEJM Evid."},{"issue":"6","key":"683_CR90","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1177\/0003319720987745","volume":"72","author":"C Wang","year":"2021","unstructured":"Wang C, Chen W, Yu M, Yang P (2021) Efficacy of trimetazidine in limiting periprocedural myocardial injury in patients undergoing percutaneous coronary intervention: a systematic review and meta-analysis. Angiology 72(6):511\u2013523. https:\/\/doi.org\/10.1177\/0003319720987745","journal-title":"Angiology"},{"issue":"21","key":"683_CR91","doi-asserted-by":"publisher","first-page":"5475","DOI":"10.3390\/ijms20215475","volume":"20","author":"N Wolska","year":"2019","unstructured":"Wolska N, Rozalski M (2019) Blood platelet adenosine receptors as potential targets for anti-platelet therapy. Int J Mol Sci 20(21):5475. https:\/\/doi.org\/10.3390\/ijms20215475","journal-title":"Int J Mol Sci"},{"issue":"2","key":"683_CR92","doi-asserted-by":"publisher","first-page":"24065","DOI":"10.31083\/RCM24065","volume":"26","author":"XM Feng","year":"2025","unstructured":"Feng XM, Zhang WH, Liu J (2025) Adenosine as an adjunctive therapy for acute myocardial infarction undergoing primary percutaneous coronary intervention: a systematic review and meta-analysis of randomized controlled trials. Rev Cardiovasc Med 26(2):24065. https:\/\/doi.org\/10.31083\/RCM24065","journal-title":"Rev Cardiovasc Med"},{"key":"683_CR93","doi-asserted-by":"publisher","unstructured":"Qian G, Zhang Y, Dong W, Jiang ZC, Li T, Cheng LQ, Zou YT, Jiang XS, Zhou H, A X, Li P, Chen ML, Su X, Tian JW, Shi B, Li ZZ, Wu YQ, Li YJ, Chen YD (2022) Effects of nicorandil administration on infarct size in patients with ST-segment-elevation myocardial infarction undergoing primary percutaneous coronary intervention: the CHANGE trial. J Am Heart Assoc 11(18): e026232. https:\/\/doi.org\/10.1161\/JAHA.122.026232","DOI":"10.1161\/JAHA.122.026232"},{"key":"683_CR94","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1007\/s00210-022-02368-3","volume":"396","author":"H Kakavand","year":"2023","unstructured":"Kakavand H, Saadatagah S, Naderian M et al (2023) Evaluating the role of intravenous pentoxifylline administration on primary percutaneous coronary intervention success rate in patients with ST-elevation myocardial infarction (PENTOS-PCI). Naunyn Schmiedebergs Arch Pharmacol 396:557\u2013565. https:\/\/doi.org\/10.1007\/s00210-022-02368-3","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"issue":"11","key":"683_CR95","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1161\/CIRCULATIONAHA.121.056177","volume":"144","author":"N Mewton","year":"2021","unstructured":"Mewton N, Roubille F, Bresson D, Prieur C, Bouleti C, Bochaton T, Ivanes F, Dubreuil O, Biere L, Hayek A, Derimay F, Akodad M, Alos B, Haider L, El Jonhy N, Daw R, De Bourguignon C, Dhelens C, Finet G, Bonnefoy-Cudraz E, Bidaux G, Boutitie F, Maucort-Boulch D, Croisille P, Rioufol G, Prunier F, Angoulvant D (2021) Effect of colchicine on myocardial injury in acute myocardial infarction. Circulation 144(11):859\u2013869. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.121.056177","journal-title":"Circulation"},{"issue":"15","key":"683_CR96","doi-asserted-by":"publisher","first-page":"1845","DOI":"10.1016\/j.jacc.2021.02.049","volume":"77","author":"K Broch","year":"2021","unstructured":"Broch K, Anstensrud AK, Woxholt S, Sharma K, T\u00f8llefsen IM, Bendz B, Aakhus S, Ueland T, Amundsen BH, Dam\u00e5s JK, Berg ES, Bj\u00f8rkelund E, Bendz C, Hopp E, Kleveland O, Stens\u00e6th KH, Opdahl A, Kl\u00f8w NE, Seljeflot I, Andersen G\u00d8, Wiseth R, Aukrust P, Gullestad L (2021) Randomized trial of interleukin-6 receptor inhibition in patients with acute ST-segment elevation myocardial infarction. J Am Coll Cardiol 77(15):1845\u20131855. https:\/\/doi.org\/10.1016\/j.jacc.2021.02.049","journal-title":"J Am Coll Cardiol"},{"issue":"4","key":"683_CR97","doi-asserted-by":"publisher","first-page":"658","DOI":"10.1111\/fcp.12988","volume":"38","author":"LN Maslov","year":"2024","unstructured":"Maslov LN, Naryzhnaya NV, Voronkov NS, Kurbatov BK, Derkachev IA, Ryabov VV, Vyshlov EV, Kolpakov VV, Tomilova EA, Sapozhenkova EV, Singh N, Fu F, Pei J (2024) The role of \u03b2-adrenergic receptors in the regulation of cardiac tolerance to ischemia\/reperfusion. Why do \u03b2-adrenergic receptor agonists and antagonists protect the heart? Fundam Clin Pharmacol 38(4):658\u2013673. https:\/\/doi.org\/10.1111\/fcp.12988","journal-title":"Fundam Clin Pharmacol"},{"issue":"4","key":"683_CR98","doi-asserted-by":"publisher","first-page":"833","DOI":"10.1007\/s10557-023-07448-x","volume":"38","author":"B Sun","year":"2024","unstructured":"Sun B, Wang CY, Chen RR (2024) Clinical efficacy and safety of early intravenous administration of beta-blockers in patients suffering from acute ST-segment elevation myocardial infarction without heart failure undergoing primary percutaneous coronary intervention: a study-level meta-analysis of randomized clinical trials. Cardiovasc Drugs Ther 38(4):833\u2013846. https:\/\/doi.org\/10.1007\/s10557-023-07448-x","journal-title":"Cardiovasc Drugs Ther"},{"issue":"10","key":"683_CR99","doi-asserted-by":"publisher","first-page":"1011","DOI":"10.1002\/clc.23894","volume":"45","author":"KR Motawea","year":"2022","unstructured":"Motawea KR, Gaber H, Singh RB, Swed S, Elshenawy S, Talat NE, Elgabrty N, Shoib S, Wahsh EA, Ch\u00e9bl P, Reyad SM, Rozan SS, Aiash H (2022) Effect of early metoprolol before PCI in ST-segment elevation myocardial infarction on infarct size and left ventricular ejection fraction: a systematic review and meta-analysis of clinical trials. Clin Cardiol 45(10):1011\u20131028. https:\/\/doi.org\/10.1002\/clc.23894","journal-title":"Clin Cardiol"},{"issue":"18","key":"683_CR100","doi-asserted-by":"publisher","first-page":"2093","DOI":"10.1016\/j.jacc.2016.02.050","volume":"67","author":"JM Garc\u00eda-Ruiz","year":"2016","unstructured":"Garc\u00eda-Ruiz JM, Fern\u00e1ndez-Jim\u00e9nez R, Garc\u00eda-Alvarez A et al (2016) Impact of the timing of metoprolol administration during STEMI on infarct size and ventricular function. J Am Coll Cardiol 67(18):2093\u20132104. https:\/\/doi.org\/10.1016\/j.jacc.2016.02.050","journal-title":"J Am Coll Cardiol"},{"issue":"1","key":"683_CR101","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1007\/s00395-021-00884-6","volume":"116","author":"R D\u00edaz- Munoz","year":"2021","unstructured":"D\u00edaz-Munoz R, Valle-Caballero MJ, Sanchez-Gonzalez J et al (2021) Intravenous metoprolol during ongoing STEMI ameliorates markers of ischemic injury: a METOCARD-CNIC trial electrocardiographic study. Basic Res Cardiol 116(1):45. https:\/\/doi.org\/10.1007\/s00395-021-00884-6","journal-title":"Basic Res Cardiol"},{"issue":"5","key":"683_CR102","doi-asserted-by":"publisher","first-page":"546","DOI":"10.1002\/phar.2110","volume":"38","author":"J Hong","year":"2018","unstructured":"Hong J, Barry AR (2018) Long-term beta-blocker therapy after myocardial infarction in the reperfusion era: a systematic review. Pharmacotherapy 38(5):546\u2013554. https:\/\/doi.org\/10.1002\/phar.2110","journal-title":"Pharmacotherapy"},{"issue":"22","key":"683_CR103","doi-asserted-by":"publisher","first-page":"2356","DOI":"10.1016\/j.jacc.2014.03.014","volume":"63","author":"G Pizarro","year":"2014","unstructured":"Pizarro G, Fern\u00e1ndez-Friera L, Fuster V, Fern\u00e1ndez-Jim\u00e9nez R, Garc\u00eda-Ruiz JM, Garc\u00eda-\u00c1lvarez A et al (2014) Long-term benefit of early pre-reperfusion metoprolol administration in patients with acute myocardial infarction: results from the METOCARD-CNIC trial (effect of Metoprolol in cardioprotection during an acute myocardial infarction). J Am Coll Cardiol 63(22):2356\u20132362. https:\/\/doi.org\/10.1016\/j.jacc.2014.03.014","journal-title":"J Am Coll Cardiol"},{"issue":"23","key":"683_CR104","doi-asserted-by":"publisher","first-page":"2705","DOI":"10.1016\/j.jacc.2016.03.522","volume":"67","author":"V Roolvink","year":"2016","unstructured":"Roolvink V, Ib\u00e1\u00f1ez B, Ottervanger JP, Pizarro G, van Royen N, Mateos A et al (2016) Early intravenous beta-blockers in patients with ST-segment elevation myocardial infarction before primary percutaneous coronary intervention. J Am Coll Cardiol 67(23):2705\u20132715. https:\/\/doi.org\/10.1016\/j.jacc.2016.03.522","journal-title":"J Am Coll Cardiol"},{"issue":"11","key":"683_CR105","doi-asserted-by":"publisher","first-page":"1021","DOI":"10.1056\/NEJMoa1505489","volume":"373","author":"TT Cung","year":"2015","unstructured":"Cung TT, Morel O, Cayla G, Rioufol G, Garcia-Dorado D, Angoulvant D et al (2015) Cyclosporine before PCI in patients with acute myocardial infarction. N Engl J Med 373(11):1021\u20131031. https:\/\/doi.org\/10.1056\/NEJMoa1505489","journal-title":"N Engl J Med"},{"issue":"10","key":"683_CR106","doi-asserted-by":"publisher","first-page":"129","DOI":"10.3390\/jcdd8100129","volume":"8","author":"G Tumminello","year":"2021","unstructured":"Tumminello G, Cereda A, Barbieri L, Biondi-Zoccai G, Lucreziotti S, Mafrici A, Carugo S (2021) Meta-analysis of placebo-controlled trials of levosimendan in acute myocardial infarction. J Cardiovasc Dev Dis 8(10):129. https:\/\/doi.org\/10.3390\/jcdd8100129","journal-title":"J Cardiovasc Dev Dis"},{"issue":"19","key":"683_CR107","doi-asserted-by":"publisher","first-page":"1255","DOI":"10.1093\/eurheartj\/ehu096","volume":"35","author":"N Siddiqi","year":"2014","unstructured":"Siddiqi N, Neil C, Bruce M et al (2014) Intravenous sodium nitrite in acute ST-elevation myocardial infarction: a randomized controlled trial (NIAMI). Eur Heart J 35(19):1255\u20131262. https:\/\/doi.org\/10.1093\/eurheartj\/ehu096","journal-title":"Eur Heart J"},{"key":"683_CR108","doi-asserted-by":"publisher","first-page":"1279","DOI":"10.1007\/s12630-015-0456-2","volume":"62","author":"S Lavi","year":"2015","unstructured":"Lavi S, Alemayehu M, McCarty D et al (2015) One-year outcome of the sevoflurane in acute myocardial infarction randomized trial. Can J Anesth\/Journal canadien d\u2019anesth\u00e9sie 62:1279\u20131286. https:\/\/doi.org\/10.1007\/s12630-015-0456-2","journal-title":"Can J Anesth\/Journal canadien d'anesth\u00e9sie"},{"issue":"16","key":"683_CR109","doi-asserted-by":"publisher","first-page":"1917","DOI":"10.1016\/j.jacc.2016.02.033","volume":"67","author":"F Beygui","year":"2016","unstructured":"Beygui F, Cayla G, Roule V et al (2016) Early aldosterone blockade in acute myocardial infarction: the ALBATROSS randomized clinical trial. J Am Coll Cardiol 67(16):1917\u20131927. https:\/\/doi.org\/10.1016\/j.jacc.2016.02.033","journal-title":"J Am Coll Cardiol"},{"key":"683_CR110","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1016\/j.freeradbiomed.2021.04.034","volume":"172","author":"A Makkos","year":"2021","unstructured":"Makkos A, \u00c1gg B, Petrovich B, Varga ZV, G\u00f6rbe A, Ferdinandy P (2021) Systematic review and network analysis of microRNAs involved in cardioprotection against myocardial ischemia\/reperfusion injury and infarction: involvement of redox signalling. Free Radic Biol Med 172:237\u2013251. https:\/\/doi.org\/10.1016\/j.freeradbiomed.2021.04.034","journal-title":"Free Radic Biol Med"},{"key":"683_CR111","doi-asserted-by":"publisher","first-page":"101908","DOI":"10.1016\/j.mito.2024.101908","volume":"78","author":"Z Chen","year":"2024","unstructured":"Chen Z, Rayner D, Morton R, Banfield L, Par\u00e9 G, Chong M (2024) The role of mitochondrial genes in ischemia-reperfusion injury: a systematic review of experimental studies. Mitochondrion 78:101908. https:\/\/doi.org\/10.1016\/j.mito.2024.101908","journal-title":"Mitochondrion"},{"issue":"1","key":"683_CR112","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1186\/s10020-025-01150-4","volume":"31","author":"DX Chen","year":"2025","unstructured":"Chen DX, Feng YY, Wang HY, Lu CH, Liu DZ, Gong C et al (2025) Metrnl ameliorates myocardial ischemia\u2013reperfusion injury by activating AMPK-mediated M2 macrophage polarization. Mol Med 31(1):98. https:\/\/doi.org\/10.1186\/s10020-025-01150-4","journal-title":"Mol Med"},{"issue":"2","key":"683_CR113","doi-asserted-by":"publisher","first-page":"550","DOI":"10.3390\/jcm9020550","volume":"9","author":"N Zagidullin","year":"2020","unstructured":"Zagidullin N, Motloch LJ, Gareeva D, Hamitova A, Lakman I, Krioni I et al (2020) Combining novel biomarkers for risk stratification of two-year cardiovascular mortality in patients with ST-elevation myocardial infarction. J Clin Med 9(2):550. https:\/\/doi.org\/10.3390\/jcm9020550","journal-title":"J Clin Med"},{"key":"683_CR114","doi-asserted-by":"publisher","first-page":"823","DOI":"10.3389\/fimmu.2019.00823","volume":"10","author":"G Ristagno","year":"2019","unstructured":"Ristagno G, Fumagalli F, Bottazzi B, Mantovani A, Olivari D, Novelli D et al (2019) Pentraxin 3 in cardiovascular disease. Front Immunol 10:823. https:\/\/doi.org\/10.3389\/fimmu.2019.00823","journal-title":"Front Immunol"},{"key":"683_CR115","doi-asserted-by":"publisher","first-page":"117954681984280","DOI":"10.1177\/1179546819842804","volume":"13","author":"M Kercheva","year":"2019","unstructured":"Kercheva M, Ryabova T, Gusakova A, Suslova TE, Ryabov V, Karpov RS (2019) Serum soluble ST2 and adverse left ventricular remodeling in patients with ST-segment elevation myocardial infarction. Clin Med Insights Cardiol 13:1179546819842804. https:\/\/doi.org\/10.1177\/1179546819842804","journal-title":"Clin Med Insights Cardiol"},{"key":"683_CR116","doi-asserted-by":"publisher","DOI":"10.1016\/j.mcpro.2025.100996","author":"HM Xue","year":"2025","unstructured":"Xue HM, Hou HT, Song Y, Chen HX, Zhang YQ, Sun WT et al (2025) Data-independent acquisition proteomics identifies plasma prostaglandin-H2D-isomerase as an early diagnostic biomarker for STEMI and NSTEMI. Mol Cell Proteomics. https:\/\/doi.org\/10.1016\/j.mcpro.2025.100996","journal-title":"Mol Cell Proteomics"},{"issue":"5","key":"683_CR117","doi-asserted-by":"publisher","first-page":"332","DOI":"10.3390\/cimb47050332","volume":"47","author":"A Martuszewski","year":"2025","unstructured":"Martuszewski A, Paluszkiewicz P, Por\u0119ba R, Ga\u0107 P (2025) Galectin-3 in cardiovascular health: a narrative review based on Life\u2019s Essential 8 and Life\u2019s Simple 7 frameworks. Curr Issues Mol Biol 47(5):332. https:\/\/doi.org\/10.3390\/cimb47050332","journal-title":"Curr Issues Mol Biol"},{"issue":"2","key":"683_CR118","doi-asserted-by":"publisher","first-page":"e1003911","DOI":"10.1371\/journal.pmed.1003911","volume":"19","author":"A Kaura","year":"2022","unstructured":"Kaura A, Hartley A, Panoulas V, Glampson B, Shah ASV, Davies J et al (2022) Mortality risk prediction of high-sensitivity C-reactive protein in suspected acute coronary syndrome: a cohort study. PLoS Med 19(2):e1003911. https:\/\/doi.org\/10.1371\/journal.pmed.1003911","journal-title":"PLoS Med"},{"issue":"7","key":"683_CR119","doi-asserted-by":"publisher","first-page":"AIoa2400190","DOI":"10.1056\/AIoa2400190","volume":"1","author":"C Lin","year":"2024","unstructured":"Lin C, Liu WT, Chang CH, Lee CC, Hsing SC, Fang WH et al (2024) Artificial intelligence\u2013powered rapid identification of ST-elevation myocardial infarction via electrocardiogram (ARISE)\u2014a pragmatic randomized controlled trial. NEJM AI 1(7):AIoa2400190. https:\/\/doi.org\/10.1056\/AIoa2400190","journal-title":"NEJM AI"},{"issue":"1","key":"683_CR120","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1186\/s12944-021-01475-z","volume":"20","author":"Y Xue","year":"2021","unstructured":"Xue Y, Shen J, Hong W, Zhou W, Xiang Z, Zhu Y et al (2021) Risk stratification of ST-segment elevation myocardial infarction (STEMI) patients using machine learning based on lipid profiles. Lipids Health Dis 20(1):48. https:\/\/doi.org\/10.1186\/s12944-021-01475-z","journal-title":"Lipids Health Dis"},{"issue":"1","key":"683_CR121","doi-asserted-by":"publisher","first-page":"12220","DOI":"10.1038\/s41598-022-16228-w","volume":"12","author":"SJ Backhaus","year":"2022","unstructured":"Backhaus SJ, Aldehayat H, Kowallick JT, Evertz R, Lange T, Kutty S et al (2022) Artificial intelligence fully automated myocardial strain quantification for risk stratification following acute myocardial infarction. Sci Rep 12(1):12220. https:\/\/doi.org\/10.1038\/s41598-022-16228-w","journal-title":"Sci Rep"},{"issue":"4","key":"683_CR122","doi-asserted-by":"publisher","first-page":"152","DOI":"10.14744\/AnatolJCardiol.2025.5237","volume":"29","author":"G Biondi-Zoccai","year":"2025","unstructured":"Biondi-Zoccai G, D\u2019Ascenzo F, Giordano S, Mirzoyev U, Erol \u00c7, Cenciarelli S et al (2025) Artificial intelligence in cardiology: general perspectives and focus on interventional cardiology. Anatol J Cardiol 29(4):152\u2013163. https:\/\/doi.org\/10.14744\/AnatolJCardiol.2025.5237","journal-title":"Anatol J Cardiol"},{"issue":"1","key":"683_CR123","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1016\/j.jmb.2018.05.044","volume":"431","author":"C Brokowski","year":"2019","unstructured":"Brokowski C, Adli M (2019) Crispr ethics: moral considerations for applications of a powerful tool. J Mol Biol 431(1):88\u2013101. https:\/\/doi.org\/10.1016\/j.jmb.2018.05.044","journal-title":"J Mol Biol"},{"key":"683_CR124","doi-asserted-by":"publisher","first-page":"100791","DOI":"10.1016\/j.imu.2021.100791","volume":"27","author":"B V\u00e1zquez","year":"2021","unstructured":"V\u00e1zquez B, Fuentes-Pineda G, Garc\u00eda F, Borrayo G, Proh\u00edas J (2021) Risk markers by sex for in-hospital mortality in patients with acute coronary syndrome: a machine learning approach. Inf Med Unlock 27:100791. https:\/\/doi.org\/10.1016\/j.imu.2021.100791","journal-title":"Inf Med Unlock"},{"issue":"3","key":"683_CR125","doi-asserted-by":"publisher","first-page":"299","DOI":"10.24875\/ACM.20000160","volume":"91","author":"GIM Raymundo-Mart\u00ednez","year":"2020","unstructured":"Raymundo-Mart\u00ednez GIM, Araiza-Garaygordobil D, Gopar-Nieto R, Lo\u00e1isiga-S\u00e1enz AE, Baeza-Herrera LA, Pohls-V\u00e1zquez R et al (2020) Diferencias de g\u00e9nero en la mortalidad en pacientes con infarto de miocardio con elevaci\u00f3n del segmento ST. Arch Cardiol Mex 91(3):299\u2013306. https:\/\/doi.org\/10.24875\/ACM.20000160","journal-title":"Arch Cardiol Mex"},{"issue":"10","key":"683_CR126","doi-asserted-by":"publisher","first-page":"3357","DOI":"10.3390\/jcm14103357","volume":"14","author":"LV Iorescu","year":"2025","unstructured":"Iorescu LV, Prisacariu I, Aboueddahab C, Taheri M, Jaiswal V, Avagimyan A et al (2025) Secondary prevention after acute coronary syndromes in women: tailored management and cardiac rehabilitation. J Clin Med 14(10):3357. https:\/\/doi.org\/10.3390\/jcm14103357","journal-title":"J Clin Med"}],"container-title":["The Egyptian Heart Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s43044-025-00683-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s43044-025-00683-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s43044-025-00683-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,5]],"date-time":"2025-09-05T07:45:35Z","timestamp":1757058335000},"score":1,"resource":{"primary":{"URL":"https:\/\/tehj.springeropen.com\/articles\/10.1186\/s43044-025-00683-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,5]]},"references-count":129,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["683"],"URL":"https:\/\/doi.org\/10.1186\/s43044-025-00683-7","relation":{},"ISSN":["2090-911X"],"issn-type":[{"value":"2090-911X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,5]]},"assertion":[{"value":"9 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 August 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 September 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable. This article is a narrative review and does not involve any studies with human participants or animals performed by any of the authors.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"83"}}